drugset / Trial / NCT02264847

Human Chorionic Gonadotrophin & Trigger

NCT02264847

Phase 3 Unknown 200 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

In women being treated with medicines to help eggs to grow (called ovulation induction), The investigators wish to know whether adding medicines (called ovulation triggers) that help to release the egg (ovulation) would lead to more women having babies without causing harm compared with not giving them ovulation triggers.

Timeline

Start
2014-10
Primary completion
2017-04
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator human chorionic gonadotropin Protein / enzyme biologic 5000 iu
Comparator Clomiphene Other / unclassified 200 mg

Indications